We recently published a list of 10 Stocks with Consistent Growth to Buy. In this article, we are going to take a look at ...

Eli Lilly (LLY) has partnered with the government of the United Kingdom to see if its blockbuster weight loss drug could help ...

Lilly’s latest investment comes on the heels of three earlier rounds of manufacturing investment at the LEAP Research and ...

US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 million expansion of its manufacturing site in ...

Mason & Associates Inc raised its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 14.0% during the ...

Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative solutions while striving to comply with federal, state and local regulatory ...

GAM Holding AG raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 55.3% in the third quarter, ...

It is suggested that the platforms could influence patients in favour of the pharma giants or lead to inappropriate ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

(RTTNews) - Eli Lilly and Company (LLY) Monday announced 1-year histologic data from the Phase 3 VIVID-1 study of mirikizumab in people with Crohn's disease, a type of inflammatory bowel disease.

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...